title: Role of lipid lowering therapy and renin angiotensin blockade in outcomes of patients with atrial fibrillation.
authors.forename: Apurva O
authors.initials: AO
authors.lastname: Badheka
authors.forename: Tushar
authors.initials: T
authors.lastname: Tuliani
authors.forename: Ankit
authors.initials: A
authors.lastname: Rathod
authors.forename: Maithili
authors.initials: M
authors.lastname: Shenoy
authors.forename: Luis
authors.initials: L
authors.lastname: Afonso
authors.forename: Sony
authors.initials: S
authors.lastname: Jacob
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012084:Renin-Angiotensin System / Q000187:drug effects*; D020521:Stroke / Q000401:mortality / Q000517:prevention & control
chemical_list: D000889:Anti-Arrhythmia Agents; D000960:Hypolipidemic Agents